The survival of HER2‐positive HR‐negative breast cancer patients was significantly affected by Stage, Age, M‐code, T‐code, N‐code, Surg, Marital, Chemotherapy, Liver, Brain, Lung, Radiation, Bone, and Hist in univariate analysis (Table 2). The gene discussed is ERBB2; the disease is breast cancer.